Fishing for Drug Targets: A Focus on Diazirine Photoaffinity Probe

1 day ago - Target identification is a high-priority, albeit challenging, aspect of drug discovery. Diazirine-based photoaffinity probes (PAPs) can fa...
2 downloads 12 Views 1014KB Size
Subscriber access provided by UNIV OF SCIENCES PHILADELPHIA

Fishing for Drug Targets: A Focus on Diazirine Photoaffinity Probe Synthesis James R. Hill, and Avril A. B. Robertson J. Med. Chem., Just Accepted Manuscript • DOI: 10.1021/acs.jmedchem.7b01561 • Publication Date (Web): 23 Apr 2018 Downloaded from http://pubs.acs.org on April 23, 2018

Just Accepted “Just Accepted” manuscripts have been peer-reviewed and accepted for publication. They are posted online prior to technical editing, formatting for publication and author proofing. The American Chemical Society provides “Just Accepted” as a service to the research community to expedite the dissemination of scientific material as soon as possible after acceptance. “Just Accepted” manuscripts appear in full in PDF format accompanied by an HTML abstract. “Just Accepted” manuscripts have been fully peer reviewed, but should not be considered the official version of record. They are citable by the Digital Object Identifier (DOI®). “Just Accepted” is an optional service offered to authors. Therefore, the “Just Accepted” Web site may not include all articles that will be published in the journal. After a manuscript is technically edited and formatted, it will be removed from the “Just Accepted” Web site and published as an ASAP article. Note that technical editing may introduce minor changes to the manuscript text and/or graphics which could affect content, and all legal disclaimers and ethical guidelines that apply to the journal pertain. ACS cannot be held responsible for errors or consequences arising from the use of information contained in these “Just Accepted” manuscripts.

is published by the American Chemical Society. 1155 Sixteenth Street N.W., Washington, DC 20036 Published by American Chemical Society. Copyright © American Chemical Society. However, no copyright claim is made to original U.S. Government works, or works produced by employees of any Commonwealth realm Crown government in the course of their duties.

Page 1 of 68 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Journal of Medicinal Chemistry

Fishing for Drug Targets: A Focus on Diazirine Photoaffinity Probe Synthesis James R. Hill and Avril A. B. Robertson* Institute for Molecular Bioscience, the University of Queensland, St Lucia, Queensland 4072, Australia Abstract Target identification is a high-priority, albeit challenging, aspect of drug discovery. Diazirine-based photoaffinity probes (PAPs) can facilitate the process by covalently capturing transient molecular interactions. This can help identify target proteins and map the ligand’s interactome. Diazirine probes have even been incorporated by cellular machinery into proteins. Embarking on the synthesis of customized PAPs, containing either an aliphatic or trifluoromethyl phenyl diazirine, can be a considerable endeavor, particularly for medicinal chemists and chemical biologists new to the field. This perspective takes a synthetic focus, aiming to summarize available routes, propose new avenues and illuminate recent advances in diazirine synthesis. Select examples of diazirine photoaffinity labelling applications have been included throughout to provide instructive definition of the advantages and limitations of the technology while simultaneously highlighting how these reagents can be applied in a practical sense.

1

Introduction Discovered in the 1960’s, 3H-diazirines (diazirines) are unusually stable three-membered

rings containing one carbon and two nitrogen atoms, with a double bond between the two nitrogen atoms.1-3 Diazirines were initially investigated as carbene precursors in spectroscopic

ACS Paragon Plus Environment

1

Journal of Medicinal Chemistry 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 2 of 68

studies and have since become widely used as photoaffinity probes (PAPs).4-5 Upon exposure to light, heat or ultrasonication6 diazirines liberate nitrogen to form carbenes, either directly or via slow photo-isomerization to the linear diazo (Scheme 1).7 Carbenes can undergo a range of reactions depending on their spin state, either singlet or triplet.8 Crucially, singlet carbenes undergo C-H and heteroatom-H insertion to cross-link with proximal species.9-10 Early aliphatic diazirines (1) were known to undergo 1,2-hydrogen rearrangements, initially limiting their utility.11 In 1973, Knowles et al. identified that 3-phenyl diazirine 2 exhibited a reduced tendency to undergo intramolecular rearrangement, improving its photolabelling utility.12 Unfortunately, photo-activation of 2 produced primarily the diazo species, causing non-specific labelling as a result of dispersion from the active site before reacting with nucleophiles.12-14 In 1980, Brunner et al. proposed the trifluoromethyl phenyl diazirine 3 (TPD) as a superior alternative because the electron withdrawing nature of the trifluoromethyl group reduced the proportion and reactivity of the formed diazo species.14 Despite an incomplete understanding of the reactivity of carbene spin states and the effect of various substituents,15-16 there is no denying the utility of diazirines as PAPs due to their favorable cross-linking properties. This perspective will focus on the synthesis and design of TPDs and aliphatic diazirines, providing a fresh view on past diazirine summaries5, 17 and complementing recent PAP reviews.18-21

2

Photoaffinity labelling PAPs are multi-component tool compounds useful for identifying ligand targets,

conducting binding site mapping, investigating protein-protein interactions and live cell imaging.18-22 PAPs contain a photocrosslinking unit, a bioactive motif and a reporter or

ACS Paragon Plus Environment

2

Page 3 of 68 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Journal of Medicinal Chemistry

purification tag (Figure 1), allowing spatio-selective cross-linking with a biological target. Fundamental to this mechanism is the photocrosslinker, which generates a highly reactive species upon ultraviolet (UV) irradiation, and the bioactive motif, which gives the PAP targetselectivity. When performing live cell photoaffinity labelling, a reporter/purification tag is included for identification of the PAP-target complex, these have been reviewed extensively elsewhere.18-22 With recombinantly expressed proteins, reporter/purification tags are not always required.23 Incorporating these three components into one biologically active compound requires a thorough understanding of the structure-activity relationships (SAR) to maintain target affinity and orientate the reactive motif in a manner allowing cross-linking.18 PAPs have a distinct advantage over electrophilic cross-linking agents, because they can exist in dormant and active states, allowing them to reach equilibrium before being activated.24-25 Furthermore, PAPs can cross-link with functional groups unreactive towards electrophilic probes, making PAPs less biased towards nucleophilic protein side chains and avoiding the need for electrophilenucleophile matching.25 Diazirines

have

a

number

of

advantages

over

other

commonly

employed

photocrosslinkers such as benzophenones, aryl azides and the more recently discovered 2-aryl-5carboxytetrazole.26 Crucially, diazirines cross-link upon exposure to longwave (~360 nm) UV irradiation, minimizing damage to proteins which occurs below 300 nm.14 Diazirines cross-link in a highly selective manner, reducing the risk of non-specific binding which can occur when reactive intermediates diffuse from the site of activation, thus increasing the confidence that cross-linking has correctly identified the target protein. The high selectivity of diazirines is derived from their cross-linking mechanism, which involves the generation of a carbene upon photo-activation. This carbene exists for picoseconds, before reacting with proximal species via

ACS Paragon Plus Environment

3

Journal of Medicinal Chemistry 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 4 of 68

C-H or heteroatom-H insertion.27 If the carbene is proximal to a protein, covalent cross-linking will occur, alternatively, the diazirine will be quenched by water.14 The propensity for diazirines to be quenched by water dictates that cross-linking yields are typically under 10%,28 and that positioning of the diazirine with respect to the active site is of heightened importance. Consequently, a number of diazirine-containing analogues should be synthesized to identify the optimal balance of target affinity and cross-linking yields. Although aliphatic diazirines can undergo undesirable rearrangements, these moieties have become increasingly popular due to their small size. Minimizing a photocrosslinker’s steric demands facilitates accomodation within the active site of target proteins, leading to higher labelling yields. This also allows strategic placement on the ligand such that the diazirine moiety can probe specific ligand-protein interactions. Furthermore by using a minimalist probe approach, the ligand’s physicochemical properties are not dramatically changed. In contrast to aliphatic diazirines, the effective size of TPDs and therefore their potential to maintain target affinity, is dependent on whether biological activity requires or merely tolerates the phenyl ring. Given that a significant proportion of drug-like compounds contain phenyl rings,29 incorporation into the bioactive motif is often possible using a nested aryl diazirine strategy (Figure 2, A). In designing a PAP for the A2A adenosine receptor agonist 4, a pre-existing phenyl ring was utilized as the photocrosslinker nesting site, to give TPD 5.30 In another example, Seifert et al. nested the TPD motif within the bicyclic core of chrom-4-one 6, a sirtuin inhibitor, to give PAP 7.23 While Hatanaka et al. nested the TPD motif within tryptophan derivatives 8, synthesizing 5- and 6-trifluoromethyldiazirinyl indoles 9.31 The nesting strategy has the advantage of minimally affecting the physicochemical properties of the parent ligand. This becomes ever more important with increasing trends towards whole cell studies32 and live-

ACS Paragon Plus Environment

4

Page 5 of 68 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Journal of Medicinal Chemistry

cell imaging where compound penetration of the cell membrane is necessary.33 Comparing compound 4 with its TPD equivalent 5, the molecular weight has increased by 90 atomic mass units, the predicted octanol-water partition coefficient (CLogP) has increased slightly from 2.6 to 2.9 and the topological polar surface area (tPSA) also increased from 91 to 116 Å2. Bioactive compounds that do not contain a phenyl ring may tolerate a TPD appended beyond the pharmacophore (Figure 2, B), alternatively a motif less vital to target affinity may be replaced with a TPD (Figure 2, C). For instance, Angelastatin A (10), a natural product with an established anti-cancer SAR, was modified by appending a TPD and alkyne to give PAP 11.34 Whereas heat shock protein 90 kDa inhibitor 12, was modified by replacing the pyranose with a TPD to give PAP 13.35 Comparing 12 with its TPD equivalent (13) the CLogP increased from 1.5 to 5.7 and the tPSA decreased from 275 to 209 Å2. These strategies may therefore have a significant effect on the ligand’s physicochemical parameters and associated membrane permeability.

3

Diazirine Synthesis The synthesis of aliphatic diazirines utilizes a well-established, three-step route (Scheme

2). This involves treating an aliphatic ketone 14 with liquid ammonia to form the imine 15, followed by reaction with hydroxylamine-O-sulfonic acid (HOSA), enabling intramolecular cyclization to the diaziridine intermediate 16.36 Facile oxidation of the diaziridine to the corresponding diazirine 17 can be achieved with several reagents including freshly prepared silver (I) oxide, iodine in the presence of triethylamine, or Hünig’s base.37 This methodology has been applied successfully to relatively complex aliphatic skeletons such as steroids and

ACS Paragon Plus Environment

5

Journal of Medicinal Chemistry 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 6 of 68

carbohydrates; however, reported literature yields of this three-step diazirine formation are typically 30-40%. Recent improvements provided a one-pot method for synthesizing aliphatic diazirines from ketones (Scheme 2). This was achieved by treating levulinic acid 14, where R = H, R’ = CH2 CO2H, with HOSA in liquid ammonia at room temperature for 12 hours, followed by the addition of potassium tert-butoxide affording the diazirine 17 in an impressive 81% yield.38 Further investigation, via systematic modification of the base used, identified a high-yielding, scalable methodology which avoided the use of costly and flammable potassium tert-butoxide.39 Sodium hydride gave an improvement over conventional three-step methods, yielding 47% product. The magnesium and calcium hydride bases were particularly poor (80% yield.48-49 Azialcohols 33 can be oxidized to the carboxylic acid 39, often in high yield, using common mild oxidants such as Jones reagent50 or Dess-Martin periodinane (DMP).33 The acid can be coupled directly to form amides 40 using typical coupling reagents, such as dicylcohexylcarbodiimide (DCC) and 1-ethyl-3-(3-

ACS Paragon Plus Environment

9

Journal of Medicinal Chemistry 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 10 of 68

dimethylaminopropyl)carbodiimide (EDCI), or first converted to the acid chloride 41 using oxalyl chloride.51 A series of alkyne-containing diazirine building blocks 42, 43 and 44 (Scheme 9) were synthesized, in good yield, with the view to minimize both photocrosslinker and alkyne click handle size, thereby maximizing the chance of efficient binding to the target protein. In this synthesis it should be possible to considerably shorten the route to the acid 43 from 45 using Jones oxidation in place of iodine and triethylamine to simultaneously form the diazirine and acid moieties from the diaziridine.50 42, 43 and 44 were appended to twelve different kinase inhibitors and used to probe for target proteins in cell-based proteomic studies. In direct comparison to the minimalist linker on staurosporone 46 to the more branched and therefore bulky design of 47, additional previously unknown protein targets were identified and later validated.52 This minimalist approach was extended in an elegant and unusual way to give the first set of PAPs for live cell imaging. Normally the alkyne click handle is used to attach a reporter/purification tag via a copper-catalyzed dipolar cycloaddition, allowing purification of the target from the cellular milleau. However, if live cell imaging is intended, this approach is not ideal. Drawing on earlier work by Weissleder et al.,53-54 Li converted the alkyne of 42 to a cyclopropene 48 suitable for bioorthogonal ligation to a fluorescent tetrazine via an inverse electron demand Diels-Alder reaction (Scheme 10). Given that there are seven synthetic steps to access iodo 42, as shown in Scheme 9, improvement of the cyclopropene 48 yield of 21% would be desirable. Nevertheless, these innovative agents were conjugated with GW841819X (49), a protein-protein interaction inhibitor of the epigenetic protein bromodomain-containing protein 4, affording cyclopropene-containing diazirines 50 and 51. These cyclopropenes were then utilized

ACS Paragon Plus Environment

10

Page 11 of 68 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Journal of Medicinal Chemistry

for bioimaging in live mammalian cells through photoactivation of the diazirine followed by in situ ligation to the tetrazine tag to give 52.22 Ligation of the cyclopropene ester derivative 50 was 10-2000 fold slower than with the alcohol variant 51 and therefore less favored. There are further developments in the tetrazine Diels-Alder reagents where these can be tuned according to pendent groups.55 Unfortunately these initial cyclopropene photocrosslinkers caused high nonspecific background labelling.33 A further example of live-cell imaging was conducted with the most advanced clinical Aurora kinase cell cycle inhibitor, MLN8237.56 Three different probes were synthesized: an alkyne 53, an alkyldiazirine-alkyne 54 and an octene 55 (Figure 4). The alkynes were used for copper-catalyzed click chemistry while the octene was reacted with a tetrazine tag for imaging. All three were used simultaneously in a multiplexed approach aiming to achieve small molecule bioimaging alongside target identification. Interestingly, the alkyldiazirine-alkyne performed as well as the octene-tetrazine upon bioimaging and the authors indicate higher quality probes are required. These first generation live-cell small molecule imaging tools are an exciting development which will undoubtedly be improved upon in the future.

Aliphatic diazirine probes have been used alongside other non-diazirine components in the generation of a chemical library based on the Ugi-azide multicomponent reaction (Scheme 11).57 Six isocyanides, eighteen carbonyl reagents (three diazirine containing) and eight amines (six diazirine containing) were reacted together in a sparse matrix format to give sixty final products. The resulting molecules each contained a diazirine moiety and an alkyne. The probes were tested in a cell based assay, using the prostate cancer cell line PC-3, with photochemical activation to induce target capture and fully map the small molecule-protein interaction network. The alkyne handle was used for enrichment by reaction with fluorescent rhodamine azide via

ACS Paragon Plus Environment

11

Journal of Medicinal Chemistry 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 12 of 68

click chemistry. Proteomic studies then successfully identified target proteins. This library contained molecules with molecular weights 300-500, typical of many orally available drugs.

Early stage fragment-based drug discovery typically involves screening of small molecular weight molecules against a particular target such that these molecules can achieve an optimal orientation when binding in a protein pocket. Larger compounds (molecular weight >300) have a greater chance of steric clash with the binding site or adopt a sub-optimal binding pose. Once the binding site is identified, fragments can be chemically elaborated through extending outwards (“growing”); alternatively, fragments which bind in close proximity may be linked together. In a novel approach, a library of fourteen small fragments (molecular weight ~ 176), based on known drugs, were coupled to a constant diazirine moiety further functionalized with an alkyne (Figure 5).32 These probes were used to develop a particularly exciting fragmentbased drug discovery screening approach in human cells (HEK293T and K562). The use of the diazirine allowed capture of transient and weak interactions mapping the entire ligand interactome in the native cellular environment, identifying over two thousand proteins. Further chemical elaboration of the identified ligands led to successful discovery of the first selective ligands for the enzyme PTGR2, the transporter SLC25A20 and the transmembrane protein PGRMC2. Throughout these studies the importance of control probes and competitors to the successful identification of protein targets was heavily emphasized. This novel platform may lead the way to discovery of ligands for orphan receptors, transcription factors and adaptor proteins many of which were considered undruggable.

There is an increasing focus on identifying the non-specific interactions of common photocrosslinkers to help eliminate falsely identified target proteins. Indeed photocrosslinker-

ACS Paragon Plus Environment

12

Page 13 of 68 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Journal of Medicinal Chemistry

based hydrophobic or electrostatic interactions with non-target proteins can obscure true targets, particularly if the activity of the probe is weak.19 Park et al. compared the protein binding profiles of an aliphatic diazirine, benzophenone and arylazide photophore, each containing an alkyne click handle.58 Three cell types were investigated HeLa, BV2 and 293T, and each photocrosslinker was activated then coupled to a common fluorescent azide moiety. Using both 1D and 2D gel electrophoresis and mass spectrometry to identify protein targets, it became evident each photocrosslinker exhibited structure-dependent proteome labelling. Furthermore, this information helped to discern between target and non-target proteins when these linkers were appended to different drug-like molecules as proof-of-concept. The authors concluded that at least two different photocrosslinkers should be used in any target identification process to distinguish between true targets common to both probes and off-target proteins common to specific photocrosslinkers. Kleiner et al. compiled a useful inventory of off-target proteins common to specific photocrosslinkers.50 It is recommended to take this protein profile into account when designing both probes and experiments. Diazirines and arylazides are considered more efficient photocrosslinkers than benzophenones50 and branched photocrosslinkers tend to give less non-specific protein labelling.59

5

Diazirine-Containing Amino Acids There have been several aliphatic and aromatic diazirine amino acid derivatives

synthesized (Figure 6) and widely used. This review will focus on the aliphatic amino acids 5662 since the aromatic derivatives 63-66 are reviewed elsewhere.21 Based on the work of Suchanek,60 photo-lysine 56 was incorporated into proteins using native mammalian translational systems in living cells.61 Post-translational modification-mediated protein interactions are

ACS Paragon Plus Environment

13

Journal of Medicinal Chemistry 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 14 of 68

ordinarily challenging to study. Such modifications can be dynamic, mediate weak/transient interactions and occur at very low levels. Diazirines make ideal tools to use in overcoming these difficult circumstances, as the light-initiated chemical reactivity allows trapping of these species. HeLa cells grown in the presence of photo-lysine were treated with UV light to activate the diazirine moiety before cell lysis and extraction of the histone content.61 Proteomic analysis of bands from western blot allowed convincing identification of histone and chromatin binding proteins, many of which were already known giving confidence in the methodology. Photo-methionine (57) and photo-leucine (59) have been used in a study to map the protein interaction network of protein kinase D2.62 HeLa cells were grown for 24 hours in media where methionine and leucine had been replaced by their diazirine equivalents prior to cell lysis. A GST-PKD2 fusion protein, immobilised on glutathione sepharose beads, was then incubated with the HeLa cell lysate and irradiated with 365 nm UV light. After washing the beads, enzymatic digestion was performed and proteomic analysis successfully identified both transient and highaffinity protein interaction partners. Synthesis of photo-lysine 56 was particularly lengthy (Scheme 12) taking 17 steps from methyl 3-hydroxypropanoate 67 and serine 68.61 Initial steps in the synthesis were conducted in parallel where serine was protected using Boc and methyl ester 69 before converting the side chain to an iodo leaving group 70. The methyl 3-hydroxypropanoate 67 was protected using a tert-butyldimethylsilyl (TBDMS) group 71 and the methyl ester converted to a thioethyl ester 72. The iodo compound 70 was converted to the organozinc intermediate using activated zinc before using in a palladium-catalyzed cross-coupling with the thioester 72 giving the product 73 in an impressive 91% yield. After deprotection of the TBDMS and methyl ester, the ketone of 74 was converted to the diazirine using the conventional HOSA, iodine and ammonia methodology in

ACS Paragon Plus Environment

14

Page 15 of 68 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Journal of Medicinal Chemistry

moderate 46% yield followed by carboxylic acid protection as the methyl ester to give 75. Intermediate 75 is in itself an interesting non-proteinogenic amino acid which could be further elaborated in multiple ways through modification of the alcohol side chain. In this case, the alcohol of the side chain was converted via the azide 76 to the amine 56. Manipulation of the protecting groups provided a number of other interesting building blocks 77-79 which may be useful in peptide synthesis. The yields reported throughout this synthesis are, for the most part, very high; however, this length of route is a formidable undertaking and shorter routes would be highly desirable. Moreover the yield of diazirine formation, in the middle of this synthesis, is 46%. This is a good yield for the transformation using these reagents; nevertheless, with newer methods available (see diazirine synthesis section), this could conceivably be improved. There have been several approaches to synthesis of photo-leucine 59, one of the earliest was patented in 2006 (Scheme 13, Route 1; yields were not well reported).63 4,4’-Azi-pentanoic acid 81 was synthesised from levulinic acid 80 using the method of Church and Weiss,37 then brominated in a three-step one-pot protocol. This involved chlorination of the acid with thionyl chloride, bromination of the α-carbon using N-bromosuccinimide/hydrogen bromide with heating at 55-80 °C for 4 hours then hydrolysis of the acid chloride back to the carboxylic acid 82. Aminolysis using ammonia in methanol for 5 days at 55 °C produced the racemic amino acid 59 in relatively poor yield (13% from the 4,4’-azi-pentanoic acid). It is perhaps useful to note that the diazirine 82 was heated for an extended period and did not completely degrade. The racemate 59 was acetylated to give 83 then enzymatically de-acetylated to give the pure L-photoleucine 59. A very similar procedure was employed without enzymatic resolution, to access photo-isoleucine 61 (Figure 5).63 A much simpler methodology (Scheme 13, Route 2) involved

ACS Paragon Plus Environment

15

Journal of Medicinal Chemistry 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 16 of 68

ozonolysis of 4,5-dehydroleucine 84, in excellent yield, followed by conversion of the resulting ketone 85 to the diazirine moiety 86 (55%).64 Two alternative routes to photo-leucine have been devised which avoid the use of expensive dehydroleucine or enzymatic resolution. The first of these routes commenced by conversion of the Boc L-aspartic acid α-methyl ester 87 side chain to the corresponding βketoester 88 (Scheme 13, Route 3).65 A simultaneous hydrogenolysis/decarboxylation was then used to give the ketone 89. Reaction to form the diazirine 86 via usual HOSA methodology proceeded in only 30% yield but the subsequent deprotection/protection chemistry proceeded smoothly to give 90. Another approach (Scheme 13, Route 4) was pursued from Boc D-aspartic acid α-tert-butyl ester 91 where the acid side chain was converted to the Weinreb amide 92.66-67 Degradation to the ketone 93 using methyl Grignard reagent did not proceed to completion whereas the use of methyllithium was much more successful, proceeding in 90% yield. As in the previous synthesis, conversion to the diazirine 94 proceeded in low yield. Deprotection of the Boc and tert-butyl ester, followed by reprotection of the amine with Boc was successful in producing (Boc)-D-photo-leucine (95) in high yield.66 Identical methodology was successful for synthesis of the related (Boc)-D-photo-methionine as had been previously published.66-68 These routes would be high yielding but the diazirine formation is only 30-35% yield. Perhaps the methods of Wang39 can be adapted to effect this conversion more efficiently. Photo-methionine can also be constructed using Strecker synthesis from the corresponding aldehyde 96 to give 57, acetylation and enzymatic resolution successfully gave the pure L-photo-methionine (57, Scheme 14).63 The starting aldehyde 96 was synthesized in two synthetic steps from levulinaldehyde dimethyl acetal.37

ACS Paragon Plus Environment

16

Page 17 of 68 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Journal of Medicinal Chemistry

Trifluoromethyl-photo-leucine 60 and methionine 58 have been synthesized (Scheme 15) in their protected form (100) and their photoactivation compared to their methyl counterparts.66 The trifluoromethyldiazirines were found to be more efficient at crosslinking but required a much lower 300-330 nm wavelength light to activate than is typical for aliphatic diazirine probes. Although these trifluoromethyl-photo probes are more efficient, synthetic routes are complicated by the electron withdrawing nature of the trifluoromethyl group and the related propensity to form stable hemiaminal intermediates. The trifluoromethyl derivatives were accessed from aldehyde 97 by reaction with Rupert-Prakash reagent69 followed by mild oxidation with DMP. The aliphatic ketone 98 was converted to the diazirine 99 via the tosyloxime methodology usually employed with TPD photoprobes. HOSA methodology was not successful, most likely due to the formation of stable hemiaminal as has previously been reported,41 in addition, the amine moiety required bis-Boc protection throughout to prevent formation of stable aminal. At the end of the synthesis, the bis-Boc was converted to the monoBoc to give 100. Boc and Fmoc protected L-photo-proline 103 and 104 can be synthesized from L-trans-4hydroxyproline 101 (Scheme 16).70 Boc protection and Jones oxidation were used to give the precursor ketone 102 followed by standard methodology to form the diazirine 103 in 31% yield from the ketone. Subsequent reactions changed the Boc protecting group to Fmoc 104. Yields in the diazirine formation step were typically low but with application of new methodology may be improved;39 moreover, the protecting group chemistry was non-optimised so again might be improved with further investigation. These syntheses show that the diazirine-containing amino acids are readily accessible and they are also tolerant of typical peptide synthesis conditions. L-Photo-leucine was used in place

ACS Paragon Plus Environment

17

Journal of Medicinal Chemistry 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 18 of 68

of leucine in the synthesis of the cyclic lipopeptide antibiotic polymyxin B3 in which the lipid tail is replaced by an alkyne click handle (Figure 7).71 The polymyxin derivative retained its biological activity and was successfully used in mode of action studies. Other studies have illustrated that these novel amino acids can be recognized by native cellular systems where they are incorporated into proteins60 or can be used in site-specific native protein ligation.68

6

TPD building blocks and FGIs Much like aliphatic diaizirines, TPDs are typically incorporated into bioactive molecules

via several key building blocks amenable to numerous FGIs. Popularlized by Nakashima et al., TPD aldehyde 105 and 106 are widely used because they are easily derivatized (Scheme 17).72 Aldehydes may be: converted to acrylonitrile derivative 107 with the corresponding Wittig reagent in excellent yield (98%) and good stereospecificity (77% trans:23% cis);73 reduced to benzyl alcohol 108 in quantitative yield with sodium borohydride;74 oxidized to carboxylic acid 109 with sodium chlorite and sulfamic acid;75 converted to ester 110 by dissolving in methanol and treating with a suspension of ammonium persulfate and sulfuric acid; refluxed with hydroxylamine hydrochloride in pyridine and ethanol to form oxime 111;76 or treated with D or L-cysteine to form thiazolidine 112.

77

Benzyl bromide TPDs (Scheme 18) are employed in high-yielding alkylation reactions under basic conditions. For example Admas et al, used 113 to alkylate an amine giving 114 in 91% yield,78 while Woll et al. alkylated propargyl alcohol with benzyl bromide 115 to give 116 in 77% yield.79 Hashimoto et al. converted benzyl bromide 117 to azide 118 using sodium azide in 66% yield.80 Azide 118 was later used in a Staudinger-Bertozzi ligation to a phosphine. In a more

intricate

example,

benzyl

bromide

113

was

ACS Paragon Plus Environment

alkylated

with

tert-butyl

2-

18

Page 19 of 68 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Journal of Medicinal Chemistry

((diphenylmethylene)amino)acetate in the presence of the cinchonidine-based asymmetric catalyst

and

2-tert-butylimino-2-diethylamino-1,3-dimethylperhydro-1,3,2-diazaphosphorine

(BEMP) as a sterically hindered base, to afford 119 in 95% yield. Subsequent deprotection with trifluoroacetic acetic (TFA) afforded photo-phenyl alanine 120 in 97% yield.72 Meta-phenol TPDs are less widespread than the para counterpart, and have to our knowledge only been employed in Williamson ether syntheses, such as the alkylation of phenol 121 with 1,6-dibromohexane to give 122.81 Para-phenol TPDs on the other hand, are frequently used in Mitsunobu-style reactions with primary alcohols. Shigenari et al. applied this method to phenol 123 and hexadecan-1-ol (and ten other primary alcohols) affording TPD ether 124 in 86% (53-97%) yield.82 Aniline 125 can: react with thiophosgene to form an isothiocyanate 126 (yield not reported);83 be oxidized to the nitroarene 127 with zirconium tert-butoxide in 83% yield;84 or treated with triphosgene to form urea 128 in 50% yield via an in situ isocyanate.85 Using para TPD aniline 129, urea formation under the same conditions afforded 130, also in 50% yield.86 This section has detailed how aldehyde, benzyl bromide, phenol and aniline containing TPDs can undergo a large range of FGIs, giving a suite of building block and also inspiration as to how these could be incorporated into bioactive molecules.

7

TPD aromatic substitution Aromatic substitution reactions in the presence of TPDs is challenging due to the perceived

low thermal stability and poor phenyl reactivity. Advances in this area are highly sought after and would aid synthetic versatility, increase the affordability of commercially available

ACS Paragon Plus Environment

19

Journal of Medicinal Chemistry 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 20 of 68

intermediates and ultimately encourage the use of TPDs as PAPs. The poor reactivity of the TPDs towards electrophilic aromatic substitution (SEAr) is attributed to the highly electron withdrawing nature of the trifluoromethyl group and the poor reactivity of the aromatic C-H bonds. Presently, only a select few SEAr reactions can be performed without electron donating substitutents, this includes Lewis acid-catalyzed (SbF5 or TiCl4) formylation of phenyl 3 to give aldehyde 105 and formation of benzyl bromide 113 with bromomethyl methyl ether in triflic acid (Scheme 21, A).72 In both instances, regiochemistry is inductively directed to the para position. To circumvent the poor reactivity of TPDs towards SEAr, Hatanka et al. demonstrated the advantage of electron donating methoxy substituents (Scheme 21, B).87 The meta methoxysubstituent (131) was preferred over the para analogue because demethylation to the phenol proceeded in higher yields.87 The electron density added by an alkoxy substituent improved the scope of SEAr, allowing the formation of aldehyde 106 in 62% yield;74 iodo 132 in 86% yield with iodine and iodobenzene di(trifluoroacetate);88 nitro 133 in 75% yield with nitric and acetic anhydride;89 ketone 134 in 93% yield with acetyl chloride and aluminium trichloride (AlCl3);90 and ester 135 in 57% yield upon thallation with thallium(III) trifluoroacetate and subsequent carbonylation with palladium(II) chloride and methanol.87 These strategies have been widely adopted, making it the predominant means of performing aromatic substitutions on the electron deficient TPDs. Diazonium salts provide a known, but under-utilized, means of performing aromatic substitutions in the presence of TPDs. In 1981, Brunner et al. showed that 3-iodo TPD 132 could be formed from the 3-diazonium TPD, without the need for additional activating groups.91 This particular nucleophilic aromatic substitution (SNAr) (Scheme 22, A) is not widely used, since it is more common to use electron donating substituents to promote iodination of phenyl C-H

ACS Paragon Plus Environment

20

Page 21 of 68 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Journal of Medicinal Chemistry

bonds. However, it hints at the plausibility of using diazonium salts to perform radicalnucelophilc aromatic substitution (SRN1). This has been published using a TPD diazonium salt, in the presence of CuCl and SO2, to form a sulfonyl chloride via a Meerwein chlorosulfo-dediazotisation reaction.92 The viability of this reaction highlights the potential to use other Sandmeyer-style reactions to perform FGIs in the presence of the TPDs, expanding synthetic access. Given the propensity to avoid heating TPDs, there are several unexplored means by which aromatic reactivity could be improved at low temperatures. Arynes are one such example, generated from aryl halides when treated with a strong base, allowing the introduction of various nucleophiles (Scheme 22, B).93 Importantly, the basic conditions required to generate arynes have previously been tolerated by TPDs.42 Alternatively, electron deficient azines such as pyridine could be used to improve electrophilicity at the C-2 and C-4 positions and promote SNAr at TPD-compatible temperatures (Scheme 22, C).94 The successful utilization of these strategies would improve synthetic access to a range of substituted trifluoromethyl aryl diazirines.

8

TPD-Compatible Reaction Conditions TPDs are known to tolerate a wide range of reaction conditions including: reduction,

oxidation, acid, base, hydrolysis, nucleophiles, electrophiles, thermal heat, metal-catalysis and ambient light. Here we provide examples of some of the more harsh conditions used in TPD synthesis. This is intended to provide a more comprehensive understanding of TPD stability, inspiring synthetic chemists to develop more efficient synthetic routes.

ACS Paragon Plus Environment

21

Journal of Medicinal Chemistry 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 22 of 68

The exposure of TPDs to acidic conditions (Scheme 23) is well tolerated at low temperatures. For example, in the aforementioned formylation of unsubstituted TPD 3, exposure to dichloromethyl methyl ether, TiCl4 and triflic acid at 0 °C was required to afford the aldehyde 105 in good (80%) yield. Furthermore, TPD-containing aniline 125 can undergo diazotization in concentrated hydrochloride acid and acetic acid below 5 °C.91-92 Subsequent chlorosulfo-dediazotisation afforded the TPD sulfonylchloride 136 in 52% yield.92 Attempts to chlorosulfonate TPD 137 in chlorosulfonic acid required the temperature to stay below -20 °C to prevent decomposition.40 After 1 hour the reaction was warmed to room temperature, affording sulfonylchoride 138.40 TPDs tolerate a range of basic conditions including hydrides, oxides and amides; however, they are certainly far from impervious. Grignard reagents are known to attack the nitrogen-nitrogen double bond of diazirines.95 While highly nucleophilic, soluble and sterically unencumbered bases, such as n-butyllithium, can cause degradation via nucleophilic attack on the diazirinyl ring.95-96 n-Butyllithium can be used in circumstances where it is consumed before the TPD component is added. An example of this is shown in Scheme 24, where the 2oxazolidone 139 was lithiated before combining with an in situ acid chloride to give 140.97 Highly soluble, strong bases may be used, provided they are non-nucleophilic and the temperature is sufficiently low. Kumar et al. elegantly used lithium diisopropylamine (LDA) to lithiate bromothiazole 141, causing halogen migration (Scheme 25). The subsequent addition of tetrahydropyran-4-one enabled the formation of an alcohol, which was then methylated to give compound 142.98 Wang et al. used the poor solubility of various nucleophilic bases to their advantage (Scheme 26). Lithium amide in liquid ammonia/diethyl ether at room temperature gave diazirine

ACS Paragon Plus Environment

22

Page 23 of 68 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Journal of Medicinal Chemistry

143 from the corresponding tosyl-oxime 144 in 96% yield. By changing the base to sodium amide or sodium hydride, diazirine ring formation was observed; however, ester ammonolysis meant the desired ester was not isolated and only amide 145 was formed. TPDs can withstand an array of non-catalytic (Scheme 27) and catalytic reductions. Hashimoto et al. used sodium methoxide with diethyl phosphite to reduce TPD-containing β,βdibromostyrenes 146 to the corresponding β-bromostyrene 147 in good yield (56-96%) (Scheme 27). Whereas, the use of sodium ethoxide under microwave (µW) irradiation caused diazirine degradation.99 Reduction of the carbonyl in 148 to methylene 149, in the presence of a TPD, can be achieved with triethylsilane and TFA.100 However, attempts to perform the same reduction with

lithium

aluminium

hydride/aluminium

trichloride,

p-tosylhydrazine/sodium

cyanoborohydride or Wolff-Kishner conditions caused TPD decomposition.100 The reduction of nitroarene 127 to the corresponding aniline is another TPD-compatible transformation. This is achieved using fresh sodium dithionite, affording moderate yields of 125 (47-58%).92, 101 With careful consideration, catalytic hydrogenations are also possible in the presence of a TPD (Scheme 28). The hydrogenation of an alkene 150 with Wilkinson’s catalyst, RhCl(PPh3)3, was selective for the carbon-carbon bonds giving 151.73 In contrast, more caution was required in palladium-catalyzed reactions. Palladium on carbon facilitated preferential hydrogenation of iodoarenes 152, typically within 1 hour; however, once hydro-deiodination is complete, TPDs (108) will reduce to the diaziridine 153.102 Sulfided platinum on carbon (5 mol %); however, enabled hydrogenation or deuteration of a TPD-containing iodothiazole 154 over 18 hours to give a good yield of 155 or 156 (70-78%).98

ACS Paragon Plus Environment

23

Journal of Medicinal Chemistry 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 24 of 68

Unsurprisingly, TPDs are stable to weak oxidants given the multitude used for diaziridine to diazirine conversion, but they also exhibit stability towards a number of stronger oxidants at low temperatures (Scheme 29). Potassium permanganate was used to oxidize benzyl alcohol 108 to the corresponding benzoic acid 157 in 91% yield at room temperature.103 Oxidation of a tolyl motif 137 to the benzoic acid 157 with potassium permanganate occurred in excellent yield (95%) when performed at 50 °C over 6 hours.104 The same conditions over 15 hours resulted in a significantly lower yield (31%), perhaps owing to destruction of the diazirine ring.105 In another example of TPDs withstanding strong oxidants, ortho-periodic acid (8 eq.), chromium trioxide (10 mol %) and acetic anhydride were used to perform an oxidative cyclization on 138 (synthesized by chlorosulfonylation of 137) via a benzoic acid intermediate, to give a low yield (28%) of 158 over the 3 steps.40 The multi-step nature of this transformation, including use of chlorosulfonic acid, makes it difficult to identify whether diazirine decomposition contributed to the low yield. Although metal-catalyzed coupling reactions see widespread use in medicinal chemistry,106 this has not translated to the synthesis of TPD probes - potentially impacting the length of synthetic routes. In the context of TPD-metal-catalyzed coupling, there are several obstacles to consider. Namely, the diazirine thermal instability and the incompatibility with several metallic reagents.95, 107-108 In spite of these issues, there are examples of both Pd and Cucatalyzed coupling (Scheme 30). Kumar et al. used tris(dibenzylideneacetone)dipalladium(0) (Pd2dba3) and 1,1′-ferrocenediyl-bis(diphenylphosphine) (dppf) to perform cross-coupling between thiols 159 and 160 and an iodoarene 161, albeit giving low yield of 155 or 142 (2229%).108 Rennhack et al. investigated iron, indium, gold and copper catalysts in an attempt to perform an aldehyde-amine-alkyne three-component coupling.109 Only copper(I) proved

ACS Paragon Plus Environment

24

Page 25 of 68 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Journal of Medicinal Chemistry

applicable to their TPD-containing aldehyde (Scheme 28). This reaction required exposure of the TPD aldehyde 105 to 60 °C for 48 hours in a sealed vial under nitrogen atmosphere, with subsequent ester cleavage affording TPD 162 in 55% yield, while the same reaction at 90 °C for 24 hours caused diazirine decomposition.108 Interestingly, the previously mentioned (Scheme 3) one-step synthesis of TPDs from tosyloximes tolerated 4 hours at 80 °C in a sealed tube. In the absence of a more systematic study, such examples provide valuable insight into the thermal stability of TPDs and their compatibility with various metal catalysts.

9

Novel TPD-Derived Photocrosslinkers Although the core structure of the TPD has remained relatively unchanged since inception,

replacing one fluorine for an additional functionality has been explored (Figure 8). This led to “all-in-one” diazirines 163 and 164 containing both an azide and an alkyne, intended as handles for Hüisgen 1,3-dipolar cycloadditions.109-110 Both all-in-one PAPs have been validated by successfully forming methanolic adducts upon UV irradiation and demonstrating click cycloadditions. Burkard et al. reported the synthesis of the two fluorous-tagged diazirines 165 and 166 to aid protein-bound PAP identification via fluorous affinity chromatography.111 Unfortunately, no purification or cross-linking data has yet been reported. Furthermore, significantly less is known about CF2 phenyl carbenes than their CF3 counterparts,112 which may have implications on the protein cross-linking efficiency of the fluorous-tagged and all-in-one diaizirines. Moreover, these additional functionalities may also add steps to already long syntheses. Leveraging the favorable properties of aryl and trifluoromethyl diazirine substituents, Kumar et al. demonstrated pyridine 167 and pyrimidine 168 diazirine analogues exhibited

ACS Paragon Plus Environment

25

Journal of Medicinal Chemistry 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 26 of 68

improved ambient light stability, with only marginal effects on UV irradiation times and the diazo-carbene ratio.113 This outcome was attributed to the introduction of electron withdrawing nitrogen atoms, causing a decrease in the molar absorption coefficient (ε) and a shift in the maximum UV absorption wavelength (λmax). Compared to phenyl derivative, the ε of pyridine 167 and pyrimidine 168 was reduced by 15% and 30% respectively, while the λmax decreased to 345 nm and 350 nm respectively. The effect on thermal stability was not determined. In addition to improving the ambient light stability of trifluoromethyl diazirines, heterocycles may provide opportunities for chemical derivatization not accessible via the phenyl variant.

10

Concluding remarks Aliphatic and trifluoromethyl phenyl diazirines, have become increasingly popular and the

range of applications is ever expanding. These useful photocrosslinkers can assist in: target identification, mapping the ligand interaction landscape within the cellular milleau, fragment based drug discovery, live cell imaging. Moreover, diazirine containing amino acids have been incorporated into proteins as they can be recognized by native cellular transcriptional machinery. Aliphatic diazirines have seen a recent increase in popularity due to their small size in comparison to the TPD unit. However with a nested strategy where an existing aromatic ring is modified with the trifluoromethyl diazirine unit, the size is not significantly increased. These are important considerations when thinking about the activity of the final probe as it may need to traverse membranes to reach its site of action and the physicochemical properties of the probes can vary significantly in comparison to the parent bioactive unit. Furthermore, additional moieties such as alkyne click handles are often incorporated and these too can affect the physicochemical properties. A number of studies are also reporting that there are “off target”

ACS Paragon Plus Environment

26

Page 27 of 68 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Journal of Medicinal Chemistry

proteins which are specific to the photocrosslinker selected and therefore more than one probe is required to conduct target identification alongside control probes. Given these recommendations it is more important than ever to increase the efficiency of the synthetic routes employed to access these useful probes. Early methods to synthesise diazirine photocrosslinkers were often low yielding; however, newer methods are emerging which significantly improve yields and reduce the number of synthetic steps required. These will undoubtedly be widely applied in the field. The TPD is a remarkably stable moiety; however, more comprehensive understanding of TPD thermal and chemical stability would encourage increased confidence to use this powerful photocrosslinker. The diazirine unit can survive an extensive array of reagents required for functional group interconversion. For the most part, conditions used are typically mild and surprisingly the diazirine ring can even survive hydrogenation with careful control of the reduction conditions. A variety of metal-catalyzed cross-coupling reactions have been successfully employed; however, there is still much scope to expand this chemistry. Diazirines have also been subjected to some very harsh reagents such as chlorosulfonic acid (at low temperature) and in some cases this has proven to be successful. Moreover, some probes have survived heating for several days. Aromatic substitution reactions of TPDs are challenging due to the poor phenyl reactivity in the presence of the electron withdrawing trifluoromethyl diazirine substituent. To mitigate this, many synthetic routes employ an electron donating group on the ring such as methoxy however this may not suit the probe design or could hinder binding of a bioactive unit to its target. Advances in synthetic methodology in this area are highly attractive in order to aid versatility. A number of diazirine containing amino acids have been synthesized, both proteinogenic and non-proteinogenic. Some synthesis such as photo-leucine and photo-methionine have been

ACS Paragon Plus Environment

27

Journal of Medicinal Chemistry 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 28 of 68

well developed with short high-yielding synthetic routes. Consequently, these two photoactivatable amino acids are commercially available. Nevertheless improvements are still possible if the newly developed chemistry to access diazirines in high yield are employed. In contrast, the 17 step photo-lysine synthesis is highly likely to be a deterrent to is widespread use and also to the likelihood of ever becoming commercially viable for compound suppliers. To devise short synthetic strategies to access these valuable tools would be an attractive prospect. The current applications of diazirine photoaffinity probes are exciting and the chemistry of these intriguing molecules is reasonably developed. However to fully exploit this technology in an efficient manner it is highly desirable to expand the synthetic methodology and shorten synthetic routes through new innovative approaches. This review provides the synthetic foundation required for medicinal chemists entering the field for the first time but also an opportunity for those more experienced to think about how best to advance this technology into the future.

7

Ancillary information

Acknowledgements J.R.H is supported by a Research Advancement Award from the Institute for Molecular Bioscience, and a University of Queensland Research Scholarship. A.A.B.R. is supported by The School of Chemistry and Molecular Bioscience at The University of Queensland, Michael J. Fox Foundation Grant and NHMRC Development Grant (APP1118973). Corresponding Author Information Email: [email protected]

ACS Paragon Plus Environment

28

Page 29 of 68 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Journal of Medicinal Chemistry

Telephone: +61 7 3346 2204

Author Contributions The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.

Abbreviations used ε, Μolar absorption coefficient; 1D, One-dimensional; 2D, Two-dimensional; λmax, Absorption wavelength; diazaphosphorine;

BEMP, CLogP,

2-tert-Butylimino-2-diethylamino-1,3-dimethylperhydro-1,3,2Octanol-water

Partition

Coefficient;

DCC,

Dicyclohexylcarbodiimide; DMAP, 4-Dimethylaminopyridine; DMP, Dess-Martin Periodinane; Dppf, 1,1’-ferrocenediyl-bis(diphenylphosphine); DSC, N,N’-Disuccinimidyl carbonate; EDCI, 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide; FGI, Functional Group Interconversion; HOSA, Hydroxylamine-O-sulfonic acid; LDA, Lithium Diisopropylamide; MS, Mass Spectrometry; MSH, O-mesitylenesulfonyl hydroxylamine; µW, Microwave irradiation; PAL, Photoaffinity Labelling; TPD, Trifluoromethyl Phenyl Diazirines; PAP, Photoaffinity Probe; Pd2dba3, tris(Dibenzylideneacetone)dipalladium (0); PL, Phospholipase; SAR, Structure-Activity Relationship; SEAr, Electrophilic Aromatic Substitution; SNAr, Nucleophilic Aromatic Substitution; SRN1, Radical-Nucleophilic Substitution; t-BuOK, Potassium tert-butoxide; TBDMS, tert-butyldimethylsilyl; TFA, Trifluoroacetic Acid; TPD, trifluoromethyl phenyl diazirine; tPSA, Topological Polar Surface Area; UV, Ultraviolet.

ACS Paragon Plus Environment

29

Journal of Medicinal Chemistry 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 30 of 68

Biographies James R. Hill is a PhD Candidate at the University of Queensland’s Institute for Molecular Bioscience, where he also completed his BSc (Hons) in chemistry. James’s research focuses the synthesis of tool compounds, namely photoaffinity probes and positron emission tomography (PET) tracers, which he applies to inflammatory disease drug discovery. In 2018, James was awarded the Fulbright Queensland Scholarship to continue his PET chemistry research at the University of Michigan. Dr Avril A. B. Robertson completed her PhD (2000) at St Andrews University before 10 years as medicinal chemist in the UK drug discovery industry, most recently as project leader in oncology at Cyclacel Ltd. In 2011, she moved to the University of Queensland as head of medicinal chemistry in the Center for Drug Design and Discovery. Her research group is focused on targeting inflammatory pathways (particularly inflammasomes), anticancer and antifungal drug discovery. She has published over 50 papers and is inventor on multiple patents. Her work on sulfonylurea based NLRP3 inflammasome inhibitors was recently commercialized to found Inflazome Ltd.

ACS Paragon Plus Environment

30

Page 31 of 68 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Journal of Medicinal Chemistry

8

References

1.

Paulsen, S. R. 3.3-Dialkyl-Diazacyclopropen-(1). Angew. Chem. 1960, 72 (21), 781-782.

2.

Abendroth, H. J.; Henrich, G. Über ein Isomeres Acetonhydrazon. Angew. Chem. 1959, 71 (8), 283-283.

3.

Schmitz, E.; Ohme, R. Cyclische Diazoverbindungen, I. Herstellung und Umsetzungen von Diazirinen. Chem. Ber. 1961, 94 (8), 2166-2173.

4.

Schmitz, E.; Habisch, D.; Stark, A. Diazirines as Carbene Precursors. Angew. Chem. Int. Ed. 1963, 2 (9), 548-548.

5.

Dubinsky, L.; Krom, B. P.; Meijler, M. M. Diazirine Based Photoaffinity Labeling. Bioorg. Med. Chem. 2012, 20 (2), 554-570.

6.

Blencowe, A.; Hayes, W. Development and Application of Diazirines in Biological and Synthetic Macromolecular Systems. Soft Matter 2005, 1 (3), 178-205.

7.

Liu, M. T. H. The Thermolysis and Photolysis of Diazirines. Chem. Soc. Rev. 1982, 11 (2), 127-140.

8.

Rosenberg, M. G.; Brinker, U. H. Constrained Carbenes. Eur. J. Org. Chem. 2006, 24, 5423-5440.

9.

Sieber, S., Activity-Based Protein Profiling. Springer: Berlin, Heidelberg, 2012; Vol. 324.

10. Nassal, M. 4'-(1-Azi-2,2,2-trifluoroethyl)phenylalanine, a Photolabile Carbene-Generating Analog of Phenylalanine. J. Am. Chem. Soc. 1984, 106 (24), 7540-7545. 11. Modarelli, D. A.; Morgan, S.; Platz, M. S. Carbene Formation, Hydrogen Migration, and Fluorescence in the Excited States of Dialkyldiazirines. J. Am. Chem. Soc. 1992, 114 (18), 7034-7041.

ACS Paragon Plus Environment

31

Journal of Medicinal Chemistry 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 32 of 68

12. Smith, R. A. G.; Knowles, J. R. Aryldiazirines. Potential Reagents for Photolabeling of Biological Receptor Sites. J. Am. Chem. Soc. 1973, 95 (15), 5072-5073. 13. Smith, R. A. G.; Knowles, J. R. The Preparation and Photolysis of 3-Aryl-3H-diazirines. J. Chem. Soc., Perkin Trans. 2 1975, (7), 686-694. 14. Brunner, J.; Senn, H.; Richards, F. M. 3-Trifluoromethyl-3-phenyldiazirine. A New Carbene Generating Group for Photolabeling Reagents. J. Biol. Chem. 1980, 255 (8), 33133318. 15. Pliego, J. R.; De Almeida, W. B.; Celebi, S.; Zhu, Z.; Platz, M. S. Singlet−Triplet Gap, and the Electronic and Vibrational Spectra of Chlorophenylcarbene:  A Combined Theoretical and Experimental Study. J. Phys. Chem. A 1999, 103 (37), 7481-7486. 16. Song, M. G.; Sheridan, R. S. Regiochemical Substituent Switching of Spin States in Aryl(trifluoromethyl)carbenes. J. Am. Chem. Soc. 2011, 133 (49), 19688-19690. 17. Das, J. Aliphatic Diazirines as Photoaffinity Probes for Proteins: Recent Developments. Chem. Rev. 2011, 111 (8), 4405-4417. 18. Murale, D. P.; Hong, S. C.; Haque, M. M.; Lee, J.-S. Photo-Affinity Labeling (PAL) in Chemical Proteomics: a Handy Tool to Investigate Protein-Protein Interactions (PPIs). Proteome Sci. 2016, 15, 14-47. 19. Smith, E.; Collins, I. Photoaffinity Labeling in Target- and Binding-Site Identification. Future Med. Chem. 2015, 7 (2), 159-183. 20. Sumranjit, J.; Chung, S. J. Recent Advances in Target Characterization and Identification by Photoaffinity Probes. Molecules 2013, 18 (9), 10425-10451. 21. Hatanaka, Y.; Hashimoto, M., Photoaffinity Labeling for Structural Probing Within Protein. Springer Japan: Tokyo, 2017.

ACS Paragon Plus Environment

32

Page 33 of 68 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Journal of Medicinal Chemistry

22. Li, Z.; Wang, D.; Li, L.; Pan, S.; Na, Z.; Tan, C. Y.; Yao, S. Q. "Minimalist" Cyclopropene-Containing Photo-Cross-Linkers Suitable for Live-Cell Imaging and Affinity-Based Protein Labeling. J. Am. Chem. Soc. 2014, 136 (28), 9990-9998. 23. Seifert, T.; Malo, M.; Lengqvist, J.; Sihlbom, C.; Jarho, E. M.; Luthman, K. Identification of the Binding Site of Chroman-4-one-Based Sirtuin 2-Selective Inhibitors using Photoaffinity Labeling in Combination with Tandem Mass Spectrometry. J. Med. Chem. 2016, 59 (23), 10794-10799. 24. Shannon, D. A.; Weerapana, E. Covalent Protein Modification: the Current Landscape of Residue-Specific Electrophiles. Curr. Opin. Chem. Biol. 2015, 24, 18-26. 25. Jörg, M.; Scammells, P. J. Guidelines for the Synthesis of Small-Molecule Irreversible Probes Targeting G Protein-Coupled Receptors. ChemMedChem 2016, 11 (14), 1488-1498. 26. Herner, A.; Marjanovic, J.; Lewandowski, T. M.; Marin, V.; Patterson, M.; Miesbauer, L.; Ready, D.; Williams, J.; Vasudevan, A.; Lin, Q. 2-Aryl-5-Carboxytetrazole as a New Photoaffinity Label for Drug Target Identification. J. Am. Chem. Soc. 2016, 138 (44), 14609-14615. 27. Hatanaka, Y. Development and Leading-Edge Application of Innovative Photoaffinity Labeling. Chem. Pharm. Bull. 2015, 63 (1), 1-12. 28. Fleming, S. Chemical Reagents in Photoaffinity Labeling. Tetrahedron 1995, 51 (46), 12479-12520. 29. Taylor, R. D.; MacCoss, M.; Lawson, A. D. G. Rings in Drugs. J. Med. Chem. 2014, 57 (14), 5845-5859.

ACS Paragon Plus Environment

33

Journal of Medicinal Chemistry 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 34 of 68

30. Muranaka, H.; Momose, T.; Handa, C.; Ozawa, T. Photoaffinity Labeling of the Human A2A Adenosine Receptor and Cross-Link Position Analysis by Mass Spectrometry. ACS Med. Chem. Lett. 2017, 8 (6), 660-665. 31. Murai, Y.; Masuda, K.; Sakihama, Y.; Hashidoko, Y.; Hatanaka, Y.; Hashimoto, M. Comprehensive Synthesis of Photoreactive (3-Trifluoromethyl)diazirinyl Indole Derivatives from 5- and 6- Trifluoroacetylindoles for Photoaffinity Labeling. J. Org. Chem. 2012, 77 (19), 8581-8587. 32. Parker, C. G.; Galmozzi, A.; Wang, Y.; Correia, B. E.; Sasaki, K.; Joslyn, C. M.; Kim, A. S.; Cavallaro, C. L.; Lawrence, R. M.; Johnson, S. R.; Narvaiza, I.; Saez, E.; Cravatt, B. F. Ligand and Target Discovery by Fragment-Based Screening in Human Cells. Cell 2017, 168 (3), 527-541.e29. 33. Pan, S.; Jang, S.-Y.; Wang, D.; Liew, S. S.; Li, Z.; Lee, J.-S.; Yao, S. Q. A Suite of “Minimalist” Photo-Crosslinkers for Live-Cell Imaging and Chemical Proteomics: Case Study with BRD4 Inhibitors. Angew. Chem. Int. Ed. 2017, 56 (39), 11816-11821. 34. Jouanneau, M.; McClary, B.; Reyes, J. C.; Chen, R.; Chen, Y.; Plunkett, W.; Cheng, X.; Milinichik, A. Z.; Albone, E. F.; Liu, J. O.; Romo, D. Derivatization of Agelastatin A Leading to Bioactive Analogs and a Trifunctional Probe. Bioorg. Med. Chem. Lett. 2016, 26 (8), 2092-2097. 35. Simon, B.; Huang, X.; Ju, H.; Sun, G.; Yang, M. Synthesis and Characterization of Photoaffinity Labelling Reagents Towards the Hsp90 C-Terminal Domain. Org. Biomol. Chem. 2017, 15 (7), 1597-1605. 36. Church, R. F. R.; Kende, A. S.; Weiss, M. J. Diazirines. I. Some Observations on the Scope of the Ammonia-Hydroxylamine-O-sulfonic Acid Diaziridine Synthesis. The Preparation

ACS Paragon Plus Environment

34

Page 35 of 68 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Journal of Medicinal Chemistry

of Certain Steroid Diaziridines and Diazirines. J. Am. Chem. Soc. 1965, 87 (12), 26652671. 37. Church, R. F. R.; Weiss, M. J. Diazirines II. Synthesis and Properties of Small Functionalized Diazirine Molecules. Observations on the Reaction of a Diaziridine with the Iodine-Iodide Ion System. J. Org. Chem. 1970, 35 (8), 2465-2471. 38. Wang, L.; Ishida, A.; Hashidoko, Y.; Hashimoto, M. Dehydrogenation of the NH−NH Bond Triggered by Potassium tert-Butoxide in Liquid Ammonia. Angew. Chem. Int. Ed. 2017, 56 (3), 870-873. 39. Wang, L.; Tachrim, Z. P.; Kurokawa, N.; Ohashi, F.; Sakihama, Y.; Hashidoko, Y.; Hashimoto, M. Base-Mediated One-Pot Synthesis of Aliphatic Diazirines for Photoaffinity Labeling. Molecules 2017, 22 (8), 1389. 40. Wang, L.; Yoshida, T.; Muto, Y.; Murai, Y.; Tachrim, Z. P.; Ishida, A.; Nakagawa, S.; Sakihama, Y.; Hashidoko, Y.; Masuda, K.; Hatanaka, Y.; Hashimoto, M. Synthesis of Diazirine-Based Photoreactive Saccharin Derivatives for the Photoaffinity Labeling of Gustatory Receptors. Eur. J. Org. Chem. 2015, 14, 3129-3134. 41. Gosselin, F.; O'Shea, P. D.; Roy, S.; Reamer, R. A.; Chen, C. Y.; Volante, R. P. Unprecedented Catalytic Asymmetric Reduction of N-H Imines. Org. Lett. 2005, 7 (2), 355-358. 42. Wang, L.; Murai, Y.; Yoshida, T.; Ishida, A.; Masuda, K.; Sakihama, Y.; Hashidoko, Y.; Hatanaka, Y.; Hashimoto, M. Alternative One-Pot Synthesis of (Trifluoromethyl)phenyldiazirines from Tosyloxime Derivatives: Application for New Synthesis of Optically Pure Diazirinylphenylalanines for Photoaffinity Labeling. Org. Lett. 2015, 17 (3), 616-619.

ACS Paragon Plus Environment

35

Journal of Medicinal Chemistry 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 36 of 68

43. Kumar, A. B.; Manetsch, R. Ammonia-Free Synthesis of 3-Trifluoromethyl-3phenyldiaziridine. Synth. Commun. 2017, 48 (6), 626-631. 44. Walter, M.; Lindhorst, T. K. A Modular System for the Preparation of Diazirine-Labeled Mannose Derivatives Using Thiourea Bridging. Synthesis 2006, 6, 952-958. 45. Hazen, S. L.; Gu, X. Affinity Probes for Defining Protein-Lipid Contacts. World Patent Application WO 2017/074937, October 25, 2016. 46. Shigdel, U. K.; Zhang, J.; He, C. Diazirine-Based DNA Photo-Cross-Linking Probes for the Study of Protein-DNA Interactions. Angew. Chem. Int. Ed. Engl. 2008, 47 (1), 90-93. 47. Liang, J.; Zhang, L.; Tan, X.-L.; Qi, Y.-K.; Feng, S.; Deng, H.; Yan, Y.; Zheng, J.-S.; Liu, L.; Tian, C.-L. Chemical Synthesis of Diubiquitin-Based Photoaffinity Probes for Selectively Profiling Ubiquitin-Binding Proteins. Angew. Chem. Int. Ed. 2017, 56 (10), 2744-2748. 48. Ai, H. W.; Shen, W.; Sagi, A.; Chen, P. R.; Schultz, P. G. Probing Protein-Protein Interactions with a Genetically Encoded Photo-Crosslinking Amino Acid. ChemBioChem 2011, 12 (12), 1854-1857. 49. Chou, C. J.; Uprety, R.; Davis, L.; Chin, J. W.; Deiters, A. Genetically encoding an aliphatic diazirine for protein photocrosslinking. Chem. Sci. 2011, 2 (3), 480-483. 50. Kleiner, P.; Heydenreuter, W.; Stahl, M.; Korotkov, V. S.; Sieber, S. A. A Whole Proteome Inventory of Background Photocrosslinker Binding. Angew. Chem. Int. Ed. 2017, 56 (5), 1396-1401. 51. Lehmann, J.; Richers, J.; Pothig, A.; Sieber, S. A. Synthesis of Ramariolide Natural Products and Discovery of their Targets in Mycobacteria. Chem. Comm. 2017, 53 (1), 107110.

ACS Paragon Plus Environment

36

Page 37 of 68 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Journal of Medicinal Chemistry

52. Li, Z.; Hao, P.; Li, L.; Tan, C. Y. J.; Cheng, X.; Chen, G. Y. J.; Sze, S. K.; Shen, H.-M.; Yao, S. Q. Design and Synthesis of Minimalist Terminal Alkyne-Containing Diazirine Photo-Crosslinkers and Their Incorporation into Kinase Inhibitors for Cell- and TissueBased Proteome Profiling. Angew. Chem. Int. Ed. 2013, 52 (33), 8551-8556. 53. Yang, K. S.; Budin, G.; Reiner, T.; Vinegoni, C.; Weissleder, R. Bioorthogonal Imaging of Aurora Kinase A in Live Cells. Angew. Chem. Int. Ed. 2012, 51 (27), 6598-6603. 54. Budin, G.; Yang, K. S.; Reiner, T.; Weissleder, R. Bioorthogonal Probes for Polo-Like Kinase 1 Imaging and Quantification. Angew. Chem. Int. Ed. 2011, 50 (40), 9378-9381. 55. Vázquez, A.; Dzijak, R.; Dračínský, M.; Rampmaier, R.; Siegl, S. J.; Vrabel, M. Mechanism-Based Fluorogenic trans-Cyclooctene-Tetrazine Cycloaddition. Angew. Chem. Int. Ed. 2017, 56 (5), 1334-1337. 56. Su, Y.; Pan, S.; Li, Z.; Li, L.; Wu, X.; Hao, P.; Sze, S. K.; Yao, S. Q. Multiplex Imaging and Cellular Target Identification of Kinase Inhibitors via an Affinity-Based Proteome Profiling Approach. Sci. Rep. 2015, 5, 7724. 57. Kambe, T.; Correia, B. E.; Niphakis, M. J.; Cravatt, B. F. Mapping the Protein Interaction Landscape for Fully Functionalized Small-Molecule Probes in Human Cells. J. Am. Chem. Soc. 2014, 136 (30), 10777-10782. 58. Park, J.; Koh, M.; Koo, J. Y.; Lee, S.; Park, S. B. Investigation of Specific Binding Proteins to Photoaffinity Linkers for Efficient Deconvolution of Target Protein. ACS Chem. Biol. 2016, 11 (1), 44-52. 59. Park, H.; Koo, J. Y.; Srikanth, Y. V. V.; Oh, S.; Lee, J.; Park, J.; Park, S. B. Nonspecific Protein Labeling of Photoaffinity Linkers Correlates with their Molecular Shapes in Living Cells. Chem. Comm. 2016, 52 (34), 5828-5831.

ACS Paragon Plus Environment

37

Journal of Medicinal Chemistry 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 38 of 68

60. Suchanek, M.; Radzikowska, A.; Thiele, C. Photo-Leucine and Photo-Methionine Allow Identification of Protein-Protein Interactions in Living Cells. Nat. Methods 2005, 2 (4), 261-267. 61. Yang, T.; Li, X.-M.; Bao, X.; Fung, Y. M. E.; Li, X. D. Photo-Lysine Captures Proteins that Bind Lysine Post-Translational Modifications. Nat. Chem. Biol. 2015, 12 (2), 70-72. 62. Haupl, B.; Ihling, C. H.; Sinz, A. Combining Affinity Enrichment, Cross-Linking with Photo-Amino Acids, and Mass Spectrometry for Probing Protein Kinase D2 Interactions. Proteomics 2017, 17 (10), 1600459. 63. Thiele, C.; Suchanek, M. Photo Activatable Amino Acids. World Patent Application WO 2006/094745, September 14 2006. 64. MacKinnon, A. L.; Garrison, J. L.; Hegde, R. S.; Taunton, J. Photo-Leucine Incorporation Reveals the Target of a Cyclodepsipeptide Inhibitor of Cotranslational Translocation. J. Am. Chem. Soc. 2007, 129 (47), 14560-14561. 65. Yang, T.; Liu, Z.; Li, X. D. Developing Diazirine-Based Chemical Probes to Identify Histone Modification ‘Readers’ and ‘Erasers’. Chem. Sci. 2015, 6 (2), 1011-1017. 66. Masuda, Y.; Aoyama, K.; Yoshida, M.; Kobayashi, K.; Ohshiro, T.; Tomoda, H.; Doi, T. Design, Synthesis, and Biological Evaluation of Beauveriolide Analogues Bearing Photoreactive Amino Acids. Chem. Pharm. Bull. 2016, 64 (7), 754-765. 67. Shi, H.; Zhang, C. J.; Chen, G. Y.; Yao, S. Q. Cell-Based Proteome Profiling of Potential Dasatinib Targets by use of Affinity-Based Probes. J. Am. Chem. Soc. 2012, 134 (6), 30013014.

ACS Paragon Plus Environment

38

Page 39 of 68 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Journal of Medicinal Chemistry

68. Vila-Perello, M.; Pratt, M. R.; Tulin, F.; Muir, T. W. Covalent Capture of PhosphoDependent Protein Oligomerization by Site-Specific Incorporation of a Diazirine PhotoCross-Linker. J. Am. Chem. Soc. 2007, 129 (26), 8068-8069. 69. Prakash, G. K.; Yudin, A. K. Perfluoroalkylation with Organosilicon Reagents. Chem. Rev. 1997, 97 (3), 757-786. 70. Van der Meijden, B.; Robinson, J. A. Synthesis and Application of Photoproline - A Photoactivatable Derivative of Proline. Arkivoc 2011, vi, 130-136. 71. van der Meijden, B.; Robinson, J. A. Synthesis of a Polymyxin Derivative for Photolabeling Studies in the Gram-Negative Bacterium Escherichia Coli. J. Pept. Sci. 2015, 21 (3), 231-235. 72. Nakashima, H.; Hashimoto, M.; Sadakane, Y.; Tomohiro, T.; Hatanaka, Y. Simple and Versatile Method for Tagging Phenyldiazirine Photophores. J. Am. Chem. Soc. 2006, 128 (47), 15092-15093. 73. Hashimoto, M.; Kato, Y.; Hatanaka, Y. Selective Hydrogenation of Alkene in (3Trifluoromethyl) Phenyldiazirine Photophor with Wilkinson’s Catalyst for Photoaffinity Labeling. Chem. Pharm. Bull. 2007, 55, 1540-1543. 74. Bentz, E. L.; Gibson, H.; Hudson, C.; Moloney, M. G.; Seldon, D. A.; Wearmouth, E. S. Aryldiazirine-Modified Pyroglutamates: Photoaffinity Labels for Glutamate. Synlett 2006, 2006 (02), 247-250. 75. Lim, E.; Ricci, J.; Jung, M. Synthesis of a Dual-Labeled Probe of Dimethyl Lithospermate B with Photochemical and Fluorescent Properties. Molecules 2011, 16 (12), 9886.

ACS Paragon Plus Environment

39

Journal of Medicinal Chemistry 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 40 of 68

76. Nury, C.; Czarny, B.; Cassar-Lajeunesse, E.; Georgiadis, D.; Bregant, S.; Dive, V. A Pan Photoaffinity Probe for Detecting Active Forms of Matrix Metalloproteinases. ChemBioChem 2013, 14 (1), 107-114. 77. Kwiatkowski, S.; Crocker, P. J.; Chavan, A. J.; Nobuyuki, I.; Haley, B. E.; Watt, D. S.; Ren-jye, H. Thiazolidine and Thiazoline Derivatives of 3-Aryl-3-Trifluoromethyldiazirines for the Preparation of Fluorescent or 35S-Radiolabeled Photoaffinity Probes. Tetrahedron Lett. 1990, 31 (15), 2093-2096. 78. Admas, T. H.; Bernat, V.; Heinrich, M. R.; Tschammer, N. Development of Photoactivatable Allosteric Modulators for the Chemokine Receptor CXCR3. ChemMedChem 2016, 11 (6), 575-584. 79. Woll, K. A.; Murlidaran, S.; Pinch, B. J.; Hénin, J.; Wang, X.; Salari, R.; Covarrubias, M.; Dailey, W. P.; Brannigan, G.; Garcia, B. A.; Eckenhoff, R. G. A Novel Bifunctional Alkylphenol Anesthetic Allows Characterization of GABAA Receptor Subunit Binding Selectivity in Synaptosomes. J. Biol. Chem. 2016, 291 (31), 20473–20486. 80. Hashimoto, M.; Hatanaka, Y. Post-biotinylation of Photocrosslinking by StaudingerBertozzi Ligation of Preinstalled Alkylazide Tag. Chem. Pharm. Bull. 2005, 53 (11), 15101512. 81. Ghiassian, S.; Ismaili, H.; Lubbock, B. D. W.; Dube, J. W.; Ragogna, P. J.; Workentin, M. S. Photoinduced Carbene Generation from Diazirine Modified Task Specific Phosphonium Salts To Prepare Robust Hydrophobic Coatings. Langmuir 2012, 28 (33), 12326-12333. 82. Toshihiko Shigenari , T. H., Shigeo Katsumura Useful Method for Direct Introduction of the Photoaffinity 3-(4-Hydroxyphenyl)-3-trifluoromethyldiazirine Group. Chem. Lett. 2004, 33 (5), 594-595.

ACS Paragon Plus Environment

40

Page 41 of 68 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Journal of Medicinal Chemistry

83. Dolder, M.; Michel, H.; Sigrist, H. 3-(Trifluoromethyl)-3-(m-isothiocyanophenyl)diazirine: Synthesis and Chemical Characterization of a Heterobifunctional Carbene-Generating Crosslinking Reagent. J. Protein Chem. 1990, 9 (4), 407-415. 84. Volke, D.; Daghish, M.; Hennig, L.; Findeisen, M.; Giesa, S.; Oehme, R.; Welzel, P. On Penicillin-Binding Protein 1b Affinity-Labeling Reagents. Helv. Chim. Acta 2003, 86 (12), 4214-4232. 85. Blum, C. A.; Caldwell, R.D.; Casaubon, R; Disch, J. S.; Fox, R. M.; Koppetsch, K.; Ng, P. Y.; Oalmann, C.; Perni, R. B.; Szczepankiewicz, B. G.; White, B. H. Substitued Bridged Urea Analogs as Sirtuin Modulators. U.S. Patent 9,765,075, September 20, 2017. 86. Zhu, B.; Zhang, H.; Pan, S.; Wang, C.; Ge, J.; Lee, J.-S.; Yao, S. Q. In Situ Proteome Profiling and Bioimaging Applications of Small-Molecule Affinity-Based Probes Derived From DOT1L Inhibitors. Chem. Eur. J. 2016, 22 (23), 7824-7836. 87. Hatanaka, Y.; Hashimoto, M.; Kurihara, H.; Nakayama, H.; Kanaoka, Y. A Novel Family of Aromatic Diazirines for Photoaffinity Labeling. J. Org. Chem. 1994, 59 (2), 383-387. 88. Hashimoto, M.; Kato, Y.; Hatanaka, Y. Simple Method for the Introduction of Iodo-Label on (3-Trifluoromethyl) phenyldiazirine for Photoaffinity Labeling. Tetrahedron Lett. 2006, 47 (20), 3391-3394. 89. Hatanaka, Y.; Hashimoto, M.; Nakayama, H.; Kanaoka, Y. Syntheses of Nitro-Substituted Aryl Diazirines. An Entry to Chromogenic Carbene Precursors for Photoaffinity Labeling. Chem. Pharm. Bull 1994, 42 (4), 826-831. 90. Hashimoto, M.; Yasumaru H.; Kensuke N. Effective Synthesis of a Carbon-linked Diazirinyl Fatty Acid Derivative via Reduction of the Carbonyl Group to Methylene with Triethylsilane and Trifluoroacetic Acid. Heterocycles 2003, 59 (1), 395-398.

ACS Paragon Plus Environment

41

Journal of Medicinal Chemistry 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 42 of 68

91. Brunner, J.; Semenza, G. Selective Labeling of the Hydrophobic Core of Membranes with 3-(Trifluoromethyl)-3-(m-[125I]Iodophenyl)Diazirine, a Carbene-Generating Reagent. Biochemistry 1981, 20 (25), 7174-7182. 92. O'Neill, L.; Coll, R; Cooper, M; Robertson, A.A.B; Schroder, K. Sulfonylureas and Related Compounds and Use of Same. World Patent Application WO 2016/131098, August 25, 2016. 93. Roberts, J. D.; Semenow, D. A.; Simmons, H. E.; Carlsmith, L. A. The Mechanism of Aminations of Halobenzenes. J. Am. Chem. Soc. 1956, 78 (3), 601-611. 94. Murakami, K.; Yamada, S.; Kaneda, T.; Itami, K. C–H Functionalization of Azines. Chem. Rev. 2017, 117 (13), 9302-9332. 95. Paget C. J.; Davis, C. S. Synthesis and in Vitro Activity of Some Aryl Diaziridines as Potential Monoamine Oxidase Inhibitors. J. Med. Chem. 1964, 7 (5), 626-628. 96. Iqbal, F. The Development of Novel Photoactivatable Antagonists for the GABA-A Receptor. Doctor of Philosophy, University College London, 2012. 97. Geurink, P. P.; Klein, T.; Prèly, L.; Paal, K.; Leeuwenburgh, M. A.; van der Marel, G. A.; Kauffman, H. F.; Overkleeft, H. S.; Bischoff, R. Design of Peptide Hydroxamate-Based Photoreactive Activity-Based Probes of Zinc-Dependent Metalloproteases. Eur. J. Org. Chem. 2010, 2010 (11), 2100-2112. 98. Kumar, N. S.; Braun, M. P.; Chaudhary, A. G.; Young, R. N. Synthesis of a TritiumLabeled Photo-Affinity Probe Based on an Atypical Leukotriene Biosynthesis Inhibitor. J. Label. Compd. Radiopharm. 2011, 54 (1), 43-50.

ACS Paragon Plus Environment

42

Page 43 of 68 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Journal of Medicinal Chemistry

99. Hashimoto, M.; Komano, T.; Nabeta, K.; Hatanaka, Y. Stereoselective Synthesis of (E) and (Z)-β-Bromostyrene Containing Trifluoromethyldiazirine for Photoaffinity Labeling. Chem. Pharm. Bull. 2005, 53 (1), 140-142. 100. Hashimoto, M.; Hatanaka, Y. Recent Progress in Diazirine-Based Photoaffinity Labeling. Eur. J. Org. Chem. 2008, 15, 2513-2523. 101. Biasotti, B.; Dallavalle, S.; Merlini, L.; Farina, C.; Gagliardi, S.; Parini, C.; Belfiore, P. Synthesis of Photoactivable Inhibitors of Osteoclast Vacuolar ATPase. Bioorganic Med. Chem. 2003, 11 (10), 2247-2254. 102. Ambroise, Y.; Mioskowski, C.; Djéga-Mariadassou, G.; Rousseau, B. Consequences of Affinity in Heterogeneous Catalytic Reactions:  Highly Chemoselective Hydrogenolysis of Iodoarenes. J. Org. Chem. 2000, 65 (21), 7183-7186. 103. Ambroise, Y.; Pillon, F.; Mioskowski, C.; Valleix, A.; Rousseau, B. Synthesis and Tritium Labeling of New Aromatic Diazirine Building Blocks for Photoaffinity Labeling and Cross‐Linking. Eur. J. Org. Chem. 2001, 20, 3961-3964. 104. Kato, K.; Kiyonaka, S.; Sawaguchi, Y.; Tohnishi, M.; Masaki, T.; Yasokawa, N.; Mizuno, Y.; Mori, E.; Inoue, K.; Hamachi, I.; Takeshima, H.; Mori, Y. Molecular Characterization of Flubendiamide Sensitivity in the Lepidopterous Ryanodine Receptor Ca2+ Release Channel. Biochemistry 2009, 48 (43), 10342-10352. 105. Mchedlidze, M. T.; Sumbatyan, N. V.; Bondar', D. A.; Taranenko, M. V.; Korshunova, G. A. New Photoreactive Cleavable Reagents with Trifluoromethyldiazirine Group. Russ. J. Bioorg. Chem. 2003, 29 (2), 177-184.

ACS Paragon Plus Environment

43

Journal of Medicinal Chemistry 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 44 of 68

106. Brown, D. G.; Bostrom, J. Analysis of Past and Present Synthetic Methodologies on Medicinal Chemistry: Where Have All the New Reactions Gone? J. Med. Chem. 2016, 59 (10), 4443-4458. 107. Liu, M. T. H.; Choe, Y.-K.; Kimura, M.; Kobayashi, K.; Nagase, S.; Wakahara, T.; Niino, Y.; Ishitsuka, M. O.; Maeda, Y.; Akasaka, T. Effect of Substituents on the Thermal Decomposition of Diazirines:  Experimental and Computational Studies. J. Org. Chem. 2003, 68 (19), 7471-7478. 108. Rennhack, A.; Jumpertz, T.; Ness, J.; Baches, S.; Pietrzik, C. U.; Weggen, S.; Bulic, B. Synthesis of a Potent Photoreactive Acidic γ-Secretase Modulator for Target Identification in Cells. Bioorg. Med. Chem. 2012, 20 (21), 6523-6532. 109. Hiramatsu, T.; Guo, Y.; Hosoya, T. 3-Azidodifluoromethyl-3H-Diazirin-3-yl Group as an All-In-One Functional Group for Radioisotope-Free Photoaffinity Labeling. Org. Biomol. Chem. 2007, 5 (18), 2916-2919. 110. Kumar, N. S.; Young, R. N. Design and Synthesis of an All-In-One 3-(1,1-Difluoroprop-2ynyl)-3H-diazirin-3-yl Functional Group for Photo-Affinity Labeling. Bioorg. Med. Chem. 2009, 17 (15), 5388-5395. 111. Burkard, N.; Bender, T.; Westmeier, J.; Nardmann, C.; Huss, M.; Wieczorek, H.; Grond, S.; von Zezschwitz, P. New Fluorous Photoaffinity Labels (F-PAL) and Their Application in V-ATPase Inhibition Studies. Eur. J. Org. Chem. 2010, 11, 2176-2181. 112. Terrabuio, L. A.; Haiduke, R. L. A.; Matta, C. F. Difluorodiazirine (CF2N2): A Comparative Quantum Mechanical Study of the First Triplet and First Singlet Excited States. Chem. Phys. Lett. 2016, 655, 96-102.

ACS Paragon Plus Environment

44

Page 45 of 68 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Journal of Medicinal Chemistry

113. Kumar, A. B.; Tipton, J. D.; Manetsch, R. 3-Trifluoromethyl-3-aryldiazirine Photolabels with Enhanced Ambient Light Stability. Chem. Commun. 2016, 52 (13), 2729-2732.

ACS Paragon Plus Environment

45

Journal of Medicinal Chemistry 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

9

Page 46 of 68

Figure and scheme legends

Scheme 1. Photo-activation of diazirines. Figure 1. PAPs covalently bind target proteins. Figure 2. Biologically active compounds and their TPD derivatives A) Nested TPDs B) Appended TPD C) Replacement TPD. Scheme 2. Typical routes used to synthesize aliphatic diazirines. Figure 3. Aliphatic diazirines synthesized using Wang’s one-pot potassium hydroxide method.39 Scheme 3. TPD synthetic routes. Scheme 4. Proposed mechanism for Wang’s diazirine synthesis.42 Scheme 5. Alternative route to form TPD via ketimine reaction with MSH.43 Scheme 6. Synthesis mannose diazirine probes. Scheme 7. 3-Azibutanol was used in synthesis of patented phospholipid photoaffinity probes.45 Scheme 8. Typical functional group interconversions with aliphatic diazirines. Scheme 9. Synthesis of minimalist alkyne-diazirine probes and staurosporone example.33, 52 Scheme 10. Synthesis of cyclopropene photolinkers and their use in live cell imaging.55 Figure 4. Three different linkers were attached to Aurora kinase inhibitor MLN8237 and used simultaneously in bioimaging and target identification.56

ACS Paragon Plus Environment

46

Page 47 of 68 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Journal of Medicinal Chemistry

Scheme 11. A sixty member diazirine containing screening library was generated using the Ugi multicomponent reaction.57

Figure 5. Fragments of known drugs modified through appending a diazirine photocross linker.32 Figure 6. Common aliphatic and aromatic diazirine amino acid derivatives. Scheme 12. Synthetic route to access photo-lysine.61 Scheme 13. Four common synthetic routes to access photo-leucine. Scheme 14. Strecker synthesis of photo-methionine. Scheme 15. Synthesis of trifluoromethyl aliphatic diazirines.66 Scheme 16. Synthesis of Boc and Fmoc protected L-photo-proline. Figure 7. L-Photo-leucine was used in place of leucine in solid phase peptide synthesis of Polymyxin B. Scheme 17. Reactions of TPD aldehydes Scheme 18. Reactions of TPD benzyl bromides. Scheme 19. Reactions of TPD phenols. Scheme 20. Reactions of TPD anilines. Scheme 21. TPD SEAr facilitated by electron donating alkoxy substituients. Scheme 22. Potential aromatic substitution strategies amenable to TPDs. Scheme 23. TPD reactions in acidic conditions.

ACS Paragon Plus Environment

47

Journal of Medicinal Chemistry 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 48 of 68

Scheme 24. TPD-compatible nBuLi reaction. Scheme 25. TPD-compatible LDA reaction. Scheme 26. TPD reactions in basic conditions. Scheme 27. TPD-compatible non-catalytic reductions. Scheme 28. TPD-compatible catalytic reductions. Scheme 29. TPD-compatible oxidations. Scheme 30. TPD-compatible metal-catalyzed coupling reactions. Figure 8. Novel TPD-derived photocrosslinkers.

ACS Paragon Plus Environment

48

Page 49 of 68

Figures and schemes

diazirine

R

R

360 nm

N N

R' singlet

- N2

R'

Y H

Y H R

R'

where Y = C or heteroatom nm

1: R & R' = aliphatic 2 : R = Ph, R' = H 3: R = Ph, R' = CF3

nm

N N

36 0

10

0 36

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Journal of Medicinal Chemistry

R R' diazo

- N2

R R' triplet carbene

ACS Paragon Plus Environment

49

Journal of Medicinal Chemistry 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

ACS Paragon Plus Environment

Page 50 of 68

50

Page 51 of 68 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Journal of Medicinal Chemistry

N N

N N

N N

N N

CO2H

CO2R R = H; 67% R = tBu; 61%

CO2H

61%

HO2C

47% N N

N N OH 75%

N N

CO2H 29%

CO2H 35% N N

N N

C9H19 52%

ACS Paragon Plus Environment

85%

89%

51

Journal of Medicinal Chemistry 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

ACS Paragon Plus Environment

Page 52 of 68

52

Page 53 of 68

Journal of Medicinal Chemistry

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

ACS Paragon Plus Environment

53

Journal of Medicinal Chemistry 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

ACS Paragon Plus Environment

Page 54 of 68

54

Page 55 of 68

Journal of Medicinal Chemistry

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

ACS Paragon Plus Environment

55

Journal of Medicinal Chemistry 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

ACS Paragon Plus Environment

Page 56 of 68

56

Page 57 of 68 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Journal of Medicinal Chemistry

HO2C

68

NH2

1. SOCl2, MeOH H3CO2C 84%

OH

2. Boc2O, Et3N CH3CN 80%

O

2. LiOH, THF/H2O 97%

HO 67

HO O

NHBoc OH N N

75

NHBoc

N N

I

70

DCC, DMAP EtSH, DCM

Zn, TMSCl, BrCH2CH2Br, Pd(PPh3)2Cl2, Toluene, THF 91%

EtS O

91% TBDMSO 72

TBDMSO

1. NH3, HOSA HO2C 2. I2, NEt3 46% (2 steps) 3. K2CO3, CH3I, DMF 80%

NHBoc

1. TsOH (cat.), H CO C 3 2 (CH3)2CO, H2O OH 96% 2. LiOH, MeOH/H2O 82%

O 74

1. TsCl, Et3N, DCM 96% 2. NaN3, DMF 90% 3. LiOH, THF/H2O 99% HO2C

NHBoc

81%

OH

71

H3CO2C

H3CO2C

69

1. TBDMSCl, imidazole, DCM 99%

H3CO

PPh3, I2, DCM NHBoc imidazole

1. PS-PPh3, THF/H2O HO2C 99% N3 2. 4 M HCl, THF 99%

NH3+Cl-

NHBoc OTBDMS O

73

CuSO4.H2O,Boc2O, NaHCO3(sat.), HO2C H2O/(CH3)2CO NH3+Cl63%

N N

HO2C

NHBoc N N

56

76

NH2

FmocOSu Na2CO3 dioxane/H2O

NHFmoc

4 M HCl, THF HO2C 99%

ACS Paragon Plus Environment

99%

NHFmoc NHBoc

NH3+ClN N 79

77

N N 78

57

Journal of Medicinal Chemistry 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 58 of 68

Route 1 HO2C

1. NH3, HOSA 2. I2, NEt3

1. SOCl2, CCl4 HO2C 2. NBS, HBr 3. NaHCO3 (aq)

HO2C

Br N N

N N

O

NH3 (aq), HO2C 55 °C

81 HO2C 59

N N 58

82 80

NH2

Porcine kidney acylase

NH2

Ac2O

HO2C

NHAc N N

N N

83

Route 2 HO2C

NHBoc

O3, Me2S -78 °C

HO2C

O

80%

84

1. NH3, HOSA HO2C 2. I2, NEt3

NHBoc

55%

85

NHBoc N N

86

Route 3 CDI, iPrMgCl NHBoc benzylmalonate,H3CO2C THF O 85% 88 OH

H3CO2C

87

NHBoc Pd/C, H3CO2C MeOH O 83% 89 O

NHBoc O

O

98%

1. NH3, HOSA 30% 2. I2, NEt3

NHFmoc

90

NHBoc

85

OBn

HO2C

HO2C LiOH

N N

HO2C

1. TFA, DCM 2. Fmoc-OSu, NaHCO3, 1,4-dioxane, H2O

86

NHBoc N N

97% Route 4 tBuO2C

NHBoc O

91

OH

isobutyl chloroformate, tBuO C 2 NMM, DCM

NHBoc O

CH3NHOCH3 90%

92

N

MeLi, THF, -78 °C

tBuO2C

NHBoc O

90% 93

O

1. NH3, HOSA 35% 2. I2, NEt3 HO2C 95

NHBoc N N

1. HCl (aq), THF 2. Boc2O, Na2CO3, 1,4-dioxane, H2O 78%

ACS Paragon Plus Environment

tBuO2C 94

NHBoc N N

58

Page 59 of 68

Journal of Medicinal Chemistry

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

ACS Paragon Plus Environment

59

Journal of Medicinal Chemistry 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

ACS Paragon Plus Environment

Page 60 of 68

60

Page 61 of 68

Journal of Medicinal Chemistry

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

ACS Paragon Plus Environment

61

Journal of Medicinal Chemistry 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 62 of 68

CF3 N

F3C

N

F3C

Triphosgene RR'NH, NEt3

O N H 128

125 Zirconium t-butoxide

S

83%

Cl

F3C

NaOH

F3C

N

50%

NH2

Cl

N

N N

RR'NH = H N

N N

CF3

N N

N

NO2 127 NCS

126

F3C

N N

N

F3C

N

Triphosgene R''NH2, NEt3

O

50% NH2 129

HN

O

NH 130

O

R''NH2 = O

NH2

O

ACS Paragon Plus Environment

62

Page 63 of 68

Journal of Medicinal Chemistry

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

ACS Paragon Plus Environment

63

Journal of Medicinal Chemistry 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

F3C

N N

NH3 (liquid), Et2O, NaH or NaNH2, rt

F3C

N

OTs

Page 64 of 68

F3C

N N

NH3 (liquid), Et2O, LiNH2, rt 96%

O

NH2 145

O

OtBu 144

ACS Paragon Plus Environment

O

OtBu 143

64

Page 65 of 68

Journal of Medicinal Chemistry

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

ACS Paragon Plus Environment

65

Journal of Medicinal Chemistry 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

ACS Paragon Plus Environment

Page 66 of 68

66

Page 67 of 68

Journal of Medicinal Chemistry

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

ACS Paragon Plus Environment

67

Journal of Medicinal Chemistry 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 68 of 68

Table of Contents Graphic

ACS Paragon Plus Environment

68